Neurofeedback for the Management of Neuropathic Pain in People with Diabetes
RecruitingNCT06603792Phase: EARLY_PHASE1Started 2024-09-01
Summary
We will conduct a high-quality, blinded, randomized controlled trial (RCT) to rigorously test the effectiveness of EEG-based NF in patients with diabetes-related neuropathic pain in: 1) reducing pain
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
82 Years
Locations
University of Southern DenmarkOdense, Denmark
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06603792